Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 14NIH 3OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Recurrence 1Hypoxia 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Diagnostic Imaging × Clear all
NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

NCT04001023 2019-08-07

OVANOX

Turku University Hospital

Phase NA Unknown
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Hypoxia, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡